EFX:NYSEEquifax, Inc. Analysis
Data as of 2026-06-12 - not real-time
$159.58
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Equifax (EFX) is trading just above its discounted cash‑flow fair value, with the market price hovering around $160 versus a DCF estimate of roughly $158, suggesting a *fair* valuation at the moment. The stock sits below its 20‑day, 50‑day and 200‑day moving averages and the 30‑day volatility is elevated at over 34%, indicating a bearish technical backdrop, yet the RSI of 38 points to a modest oversold condition and the MACD histogram has turned slightly positive, hinting at a potential short‑term bounce. Recent earnings beat expectations, revenue grew 14% year‑over‑year, and free cash flow remains robust, supporting the current 1.4% dividend with a comfortable payout ratio under 40%. The company also earned a leadership spot in Javelin Strategy & Research’s 2026 Identity Protection Vendor Scorecard and launched a new partnership in Poland, providing a fresh growth catalyst in its core consumer‑identity segment.
From a fundamentals perspective, the forward PE of about 15× and a forward‑PE advantage over the industry average signal a *blend* of growth and value characteristics, while a debt‑to‑equity ratio above 100% is mitigated by strong operating cash flow and a modest beta, keeping overall risk moderate. The diversified geographic footprint spreads exposure, and the increasing volume trend enhances liquidity, making the stock a candidate for a *buy* on the short‑term rebound and a *hold* or *buy* on medium to long horizons as the business capitalizes on data‑analytics demand and dividend income.
From a fundamentals perspective, the forward PE of about 15× and a forward‑PE advantage over the industry average signal a *blend* of growth and value characteristics, while a debt‑to‑equity ratio above 100% is mitigated by strong operating cash flow and a modest beta, keeping overall risk moderate. The diversified geographic footprint spreads exposure, and the increasing volume trend enhances liquidity, making the stock a candidate for a *buy* on the short‑term rebound and a *hold* or *buy* on medium to long horizons as the business capitalizes on data‑analytics demand and dividend income.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Oversold RSI suggests near‑term upside
- Support level near $154 provides downside cushion
- Positive identity‑protection award and new partnership boost sentiment
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation is close to fair value with limited upside
- Stable cash flow sustains dividend and debt servicing
- Revenue growth and expanding data services underpin earnings stability
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term demand for credit and identity data analytics
- Attractive dividend yield with sustainable payout
- Strategic global expansion mitigates concentration risk
Key Metrics & Analysis
Financial Health
Revenue Growth14.30%
Profit Margin11.12%
P/E Ratio28.1
ROE14.37%
ROA6.27%
Debt/Equity113.35
P/B Ratio4.2
Op. Cash Flow$1.6B
Free Cash Flow$1.0B
Industry P/E30.4
Technical Analysis
TrendBearish
RSI38.1
Support$153.91
Resistance$179.62
MA 20$165.71
MA 50$173.43
MA 200$205.51
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71
Valuation
Fair Value$158.53
Target Price$223.24
Upside/Downside39.89%
GradeFair
TypeBlend
Dividend Yield1.40%
Risk Assessment
Beta0.74
Volatility34.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.